Follow
Michael Garshick
Michael Garshick
Assistant professor. NYU Langone Health
Verified email at nyulangone.org
Title
Cited by
Cited by
Year
C-reactive protein and clinical outcomes in patients with COVID-19
NR Smilowitz, D Kunichoff, M Garshick, B Shah, M Pillinger, JS Hochman, ...
European heart journal 42 (23), 2270-2279, 2021
3842021
Apolipoprotein AI) promotes atherosclerosis regression in diabetic mice by suppressing myelopoiesis and plaque inflammation
TJ Barrett, E Distel, AJ Murphy, J Hu, MS Garshick, Y Ogando, J Liu, ...
Circulation 140 (14), 1170-1184, 2019
902019
Cardiovascular Risk in Patients With Psoriasis: JACC Review Topic of the Week
MS Garshick, NL Ward, JG Krueger, JS Berger
Journal of the American College of Cardiology 77 (13), 1670-1680, 2021
872021
Inflammasome signaling and impaired vascular health in psoriasis
MS Garshick, TJ Barrett, T Wechter, S Azarchi, JU Scher, A Neimann, ...
Arteriosclerosis, thrombosis, and vascular biology 39 (4), 787-798, 2019
752019
Neutrophil subsets, platelets, and vascular disease in psoriasis
HL Teague, NJ Varghese, LC Tsoi, AK Dey, MS Garshick, JI Silverman, ...
JACC: Basic to Translational Science 4 (1), 1-14, 2019
682019
Activated platelets induce endothelial cell inflammatory response in psoriasis via COX-1
MS Garshick, M Tawil, TJ Barrett, CM Salud-Gnilo, M Eppler, A Lee, ...
Arteriosclerosis, thrombosis, and vascular biology 40 (5), 1340-1351, 2020
562020
CCL20 in psoriasis: A potential biomarker of disease severity, inflammation, and impaired vascular health
YA Elnabawi, MS Garshick, M Tawil, TJ Barrett, EA Fisher, KL Sicco, ...
Journal of the American Academy of Dermatology 84 (4), 913-920, 2021
352021
Cardiovascular risk factor control and lifestyle factors in young to middle-aged adults with newly diagnosed obstructive coronary artery disease
MS Garshick, GD Vaidean, A Vani, JA Underberg, JD Newman, JS Berger, ...
Cardiology 142 (2), 83-90, 2019
352019
Psoriasis and cardiovascular disease: novel mechanisms and evolving therapeutics
B Weber, JF Merola, ME Husni, M Di Carli, JS Berger, MS Garshick
Current atherosclerosis reports 23, 1-11, 2021
312021
The use of primary prevention statin therapy in those predisposed to atherosclerosis
M Garshick, JA Underberg
Current atherosclerosis reports 19, 1-8, 2017
312017
COVID-19 and the heart and vasculature: novel approaches to reduce virus-induced inflammation in patients with cardiovascular disease
BS Kadosh, MS Garshick, J Gaztanaga, KJ Moore, JD Newman, ...
Arteriosclerosis, thrombosis, and vascular biology 40 (9), 2045-2053, 2020
282020
Characterization of PCSK9 in the blood and skin of psoriasis
MS Garshick, Y Baumer, AK Dey, R Grattan, Q Ng, HL Teague, ZX Yu, ...
Journal of Investigative Dermatology 141 (2), 308-315, 2021
272021
Location of acute coronary artery thromboses in patients with and without chronic kidney disease
DM Charytan, RE Kuntz, M Garshick, S Candia, MF Khan, L Mauri
Kidney international 75 (1), 80-87, 2009
212009
Cardiovascular and venous thromboembolic risk with Janus kinase inhibitors in immune‐mediated inflammatory diseases: a systematic review and meta‐analysis of randomized trials
MH Maqsood, BN Weber, RH Haberman, KI Lo Sicco, S Bangalore, ...
ACR Open Rheumatology 4 (10), 912-922, 2022
172022
Reduction in dietary trans fat intake is associated with decreased LDL particle number in a primary prevention population
M Garshick, H Mochari-Greenberger, L Mosca
Nutrition, Metabolism and Cardiovascular Diseases 24 (1), 100-106, 2014
162014
A randomized open-label clinical trial of lipid-lowering therapy in psoriasis to reduce vascular endothelial inflammation
MS Garshick, K Drenkova, TJ Barrett, F Schlamp, EA Fisher, S Katz, ...
The Journal of investigative dermatology 142 (6), 1749, 2022
142022
Reshaping of the gastrointestinal microbiome alters atherosclerotic plaque inflammation resolution in mice
MS Garshick, C Nikain, M Tawil, S Pena, TJ Barrett, BG Wu, Z Gao, ...
Scientific reports 11 (1), 8966, 2021
142021
A case of cardiogenic shock secondary to complement-mediated myopericarditis from influenza B infection
M Siskin, S Rao, A Rapkiewicz, S Bangalore, M Garshick
Canadian Journal of Cardiology 33 (10), 1335. e1-1335. e3, 2017
132017
Psoriasis and cardiovascular disease—an ounce of prevention is worth a pound of cure
MS Garshick, JS Berger
JAMA dermatology 158 (3), 239-241, 2022
102022
Ustekinumab reduces serum protein levels associated with cardiovascular risk in psoriasis vulgaris
M Koschitzky, K Navrazhina, MS Garshick, J Gonzalez, J Han, S Garcet, ...
Experimental dermatology 31 (9), 1341-1351, 2022
92022
The system can't perform the operation now. Try again later.
Articles 1–20